Aptevo Therapeutics Inc (APVO) — Cash Flow Quality Index
Aptevo Therapeutics Inc (APVO) has a Cash Flow Quality Index of 1.65x as of March 2023. Operating cash flow of $4.57 Million exceeds net income of $2.77 Million, indicating high earnings quality where cash backs reported profits. Also explore APVO current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aptevo Therapeutics Inc Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Aptevo Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Aptevo Therapeutics Inc (APVO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Aptevo Therapeutics Inc (2017–2022)
Year-by-year earnings quality comparison for Aptevo Therapeutics Inc. For live market cap and the full company financial profile, see how much is Aptevo Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.62x | $-21.02 Million | $8.03 Million | ▲ +56.1% |
| 2017 | -5.96x | $-41.57 Million | $6.97 Million | — |